Blepharitis Pipeline Review, H1 2020 – ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Blepharitis Pipeline Review, H1 2020" drug pipelines has been added to ResearchAndMarkets.com's offering. Blepharitis Pipeline Review, H1 2020, provides comprehensive information on the therapeutics under development for Blepharitis (Ophthalmology), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide covers the descriptive pharmacological action of the therapeutics, its c